An Efficacy, Safety, Tolerability and Dose Finding Study of XXB750 in Resistant Hypertension Patients.
Clinical trial NCT05562934 · COMPLETED
Trial details
- NCT number
- NCT05562934
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-08
- Primary completion
- 2024-07-02
- Enrollment
- 189
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.